Skip to content
Home/GPs/MIG Capital
DetailCard
MIG Capital

MIG Capital

Munich, Germany·Founded 2004··mig.ag

MIG Capital is a Munich-based venture capital manager that invests in early and growth-stage deeptech and life-sciences companies across German-speaking Europe through its sequential retail MIG Fonds (MIG Fonds 1 to 18), managing roughly 1.3 billion euros for private investors. It is best known as an early backer of BioNTech and has floated or sold companies including BioNTech, Immatics, BRAIN, NFON and Siltectra.

AUM
€1.3B
Funds
6
vintages 2007–2024
Portfolio
31
Exits
12

MIG Capital is a Munich venture capital firm with €1.3B AUM, 31 active companies and 12 exits.

Key takeaways
  • ·5 exits in the last 5 years · consistent DPI cadence.
  • ·Average hold across 12 realized deals: 9 years.
  • ·Top sector focus: Biotech (37% of portfolio).
  • ·Fund cadence: ~3Y between vintages · last raise 2024.

Sector breakdown

43 companies
Biotech
16 · 37%
Deep Tech
10 · 23%
MedTech
5 · 12%
Industrials
3 · 7%
HealthTech
2 · 5%
Logistics
1 · 2%
ClimateTech
1 · 2%
Aerospace & Defence
1 · 2%

Geography breakdown

7 geographies
Germany
31 · 72%
France
5 · 12%
Netherlands
2 · 5%
Austria
2 · 5%
US
1 · 2%
Finland
1 · 2%
Denmark
1 · 2%

Key facts

HQMunich, Germany
Founded2004
Employees20+
Websitemig.ag

Recent exits

German Bionic

MIG Capital sold German Bionic to Archimedes Partners in 2025 after 5 years.

MIG Capital sold Advanced Medical Balloons to Stryker in 2025 after 10 years.

Biocrates

MIG Capital sold Biocrates to Bruker Corporation in 2025 after 6 years.

MIG Capital sold Cynora to Samsung Display in 2022 after 10 years.

Coverage notes

6 funds tracked, 43 portfolio companies (31 active · 12 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund MIG Capital has raised, with its portfolio companies. Hand-checked from public filings.

6 funds
MIG Fonds 18
VC2024€100M3 assets

Unrealized

3 held
CompanyEntry
CoreMedic
MedTech · Germany
2025
NcodiN
Deep Tech · France
2025
TIBEAY Biosciences
Biotech · Netherlands
2026
MIG Fonds 17Active
Evergreen20227 assets1 exits

Unrealized

7 held
CompanyEntry
ASTRA Therapeutics
Biotech · Germany
2025
GlassPoint
ClimateTech · US
2024
HawkCell
MedTech · France
2024
IQM Quantum Computers
Deep Tech · Finland
2019
Look Up Space
Aerospace & Defence · France
2023
SciRhom
Biotech · Germany
2024
TALPA Solutions
Data & Analytics · Germany
2023

Realized

1 exit
CompanyEntryExitTypeBuyerMOIC
German Bionic
Logistics · Germany
20202025SecondaryArchimedes Partners–
MIG Fonds 16Active
Evergreen2019€148M12 assets2 exits

Unrealized

12 held
CompanyEntry
Hypros
HealthTech · Germany
2018
Inbolt
Deep Tech · France
2022
Innatera
Deep Tech · Netherlands
2020
iOmx Therapeutics
Biotech · Germany
2021
Kewazo
Construction · Germany
2018
Liva Healthcare
Industrials · Denmark
2019
mbiomics
Biotech · Germany
2023
Mimi Hearing Technologies
Industrials · Germany
2021
NeraCare
MedTech · Germany
2020
November
Deep Tech · Germany
2018
Temedica
Industrials · Germany
2020
Zadient Technologies
Deep Tech · France
2021

Realized

2 exits
CompanyEntryExitTypeBuyerMOIC
Advanced Medical Balloons
MedTech · Germany
20152025Trade SaleStryker–
Biocrates
Biotech · Austria
20192025Trade SaleBruker Corporation–
MIG Fonds 15Active
Evergreen20153 assets2 exits

Unrealized

3 held
CompanyEntry
GWA Hygiene
HealthTech · Germany
2018
Konux
Mobility · Germany
2016
NavVis
Deep Tech · Germany
2014

Realized

2 exits
CompanyEntryExitTypeBuyerMOIC
Cynora
Deep Tech · Germany
20122022Trade SaleSamsung Display–
Siltectra
Deep Tech · Germany
20112018Trade SaleInfineon Technologies–
MIG Fonds 8Active
Evergreen20090 assets3 exits

Realized

3 exits
CompanyEntryExitTypeBuyerMOIC
BioNTech
Biotech · Germany
20082021IPO––
Immatics
Biotech · Germany
20102020IPOARYA Sciences Acquisition Corp.–
NFON
Telecom · Germany
20092018IPO––
MIG Fonds 5Active
Evergreen20076 assets4 exits

Unrealized

6 held
CompanyEntry
advanceCOR
Biotech · Germany
2012
AFFiRiS
Biotech · Austria
2006
AmSilk
Biotech · Germany
2008
instrAction
Deep Tech · Germany
2008
Isarna Therapeutics
Biotech · Germany
2005
Od-os
MedTech · Germany
2008

Realized

4 exits
CompanyEntryExitTypeBuyerMOIC
BRAIN Biotech
Biotech · Germany
20062016IPO––
Ganymed Pharmaceuticals
Biotech · Germany
20072016Trade SaleAstellas Pharma–
Immatics
Biotech · Germany
20102020IPOAthos–
SuppreMol
Biotech · Germany
20072015Trade SaleBaxter International–

Frequently asked questions

What investment strategy does MIG Capital focus on?
MIG Capital focuses on VC, Growth strategies in the private equity space.
How many portfolio companies does MIG Capital have?
MIG Capital has 31 active portfolio companies and 12 completed exits and 6 funds tracked on GP Intel.
Where is MIG Capital headquartered?
MIG Capital is headquartered in Munich, Germany.
What is MIG Capital's assets under management?
MIG Capital manages approximately €1.3B in assets under management.
When was MIG Capital founded?
MIG Capital was founded in 2004.
What sectors does MIG Capital invest in?
MIG Capital invests across Healthcare, TMT, Industrials, Software, Energy.
What are MIG Capital's recent exits?
Recent realized exits by MIG Capital include: German Bionic (2025) to Archimedes Partners; Advanced Medical Balloons (2025) to Stryker; Biocrates (2025) to Bruker Corporation; Cynora (2022) to Samsung Display; Immatics (2020) to ARYA Sciences Acquisition Corp.; Immatics (2020) to Athos; Siltectra (2018) to Infineon Technologies; Ganymed Pharmaceuticals (2016) to Astellas Pharma.
Look up another firm or company
Last updated August 2026 · Sourced from public filings · Report an issue